Browsing by Author "Haberal, M."
Now showing 1 - 20 of 108
- Results Per Page
- Sort Options
Item 1.5-Tesla Magnetic Resonance-Guided Adaptive Stereotactic Body Radiotherapy for Liver Malignancies(2023) Onal, C.; Yavas, G.; Yavas, C.; Arslan, G.; Efe, E.; Haberal, M.Item Alkaline Phosphatase a New Marker for Graft Outcome and High Pulse Wave Velocity in Renal Transplant Recipients(2017) Sezer, S.; Tutal, E.; Bal, Z.; Demirci, B.; Haberal, M.; 0000-0002-3462-7632; AAZ-5795-2021; AAJ-8097-2021Item Association Between Vitamin D Level and Anemia in Pediatric Renal Transplant Patients(2016) Avci, B.; Baskin, E.; Gulleroglu, K.; Kantar, A.; Moray, G.; Haberal, M.; 0000-0003-1434-3824; 0000-0002-5375-379X; 0000-0003-1434-3824; 0000-0003-2498-7287; 0000-0003-4361-8508; 0000-0002-3462-7632; AAJ-8833-2021; GYU-5220-2022; F-3294-2013; AAE-1041-2021; B-5785-2018; AAJ-8097-2021Item Atypical Mycobacterial Infection of The Duodenum: A Histological Whipple's Disease Mimic in A Renal Allograft Recipient(2018) Ayva, E. S.; Tepeoglu, M.; Ozdemir, B. H.; Haberal, M.; https://orcid.org/0000-0002-2280-8778; https://orcid.org/0000-0002-9894-8005; https://orcid.org/0000-0002-7528-3557; https://orcid.org/0000-0002-3462-7632; AAK-1967-2021; AAK-5222-2021; X-8540-2019; AAJ-8097-2021Item Autopsy-Determined Causes of Death Following Kidney Transplantation(2014) Ayva, E. S.; Ozdemir, B. H.; Ozkan, E. Akar; Atilgan, A. Ok; Haberal, M.; https://orcid.org/0000-0002-2280-8778; https://orcid.org/0000-0002-7528-3557; https://orcid.org/0000-0001-8595-8880; https://orcid.org/0000-0002-3462-7632; AAK-1967-2021; X-8540-2019; AAK-3333-2021; AAJ-8097-2021Item Baskent University Expanded Criteria for Hepatocellular Carcinoma (HCC): The Importance of The Histopathological Features As A Part of The Evaluation Criteria For Liver Transplantation(2018) Ozgun, G.; Ozdemir, H.; Moray, G.; Reyhan, Haberal N.; Akdur, A.; Kirnap, M.; Haberal, M.; https://orcid.org/0000-0002-7528-3557; https://orcid.org/0000-0003-2498-7287; https://orcid.org/0000-0001-9852-9911; https://orcid.org/0000-0002-8726-3369; https://orcid.org/0000-0002-3462-7632; X-8540-2019; AAE-1041-2021; AAK-4587-2021; AAA-3068-2021; AAH-9198-2019; AAJ-8097-2021Item Biliary Reconstruction with PTFE Graft in Liver Transplantation(2018) Haberal, M.; Soy, Ayvazoglu E. H.; Moray, G.; Torgay, A.; Ozdemir, H.; https://orcid.org/0000-0002-3462-7632; https://orcid.org/0000-0002-0993-9917; https://orcid.org/0000-0003-2498-7287; https://orcid.org/0000-0002-6829-3300; https://orcid.org/0000-0002-7528-3557; AAJ-8097-2021; AAC-5566-2019; AAE-1041-2021; AAJ-5221-2021; X-8540-2019Item Bioimpedance Analysis Reveals Graft Function in Renal Transplant Recipients(2014) Sezer, S.; Demirci, B.; Guliyev, O.; Colak, T.; Sayin, C.; Haberal, M.; https://orcid.org/0000-0002-7326-8388; https://orcid.org/0000-0002-8372-7840; https://orcid.org/0000-0002-3462-7632; JYQ-2550-2024; AAJ-8554-2021; AAJ-8097-2021Item Biopsy- Diagnosed Renal Disease in Patients With Liver Transplantation(2014) Ozdemir, B.; Terzi, A.; Taslica, F.; Ozdemir, F.; Kirnap, M.; Haberal, M.; https://orcid.org/0000-0002-7528-3557; https://orcid.org/0000-0002-1225-1320; https://orcid.org/0000-0002-5682-0943; https://orcid.org/0000-0002-3462-7632; X-8540-2019; F-7546-2013; AAK-1697-2021; AAH-9198-2019; AAJ-8097-2021Item BLOOD STREAM INFECTIONS DUE TO EXTREMELY DRUG-RESISTANT GRAM NEGATIVE PATHOGENS IN SOLID ORGAN TRANSPLANT RECIPIENTS: EPIDEMIOLOGY, RISK FACTORS AND MORTALITY(2019) Erol, C.; Melike, H. Demirkaya; Soy, E. Ayvazoglu; Arslan, H.; Haberal, M.Item Can neoadjuvant local ablation be an alternative to liver transplantation for hepatocellular carcinoma patients?(2021) Soy, Ayvazoglu E. H.; Boyvat, F.; Coskun, M.; Haberal, M.; 0000-0002-0993-9917; 0000-0002-3462-7632; AAC-5566-2019; AAJ-8097-2021; F-4230-2011Item Can we prevent bleeding or seeding after biopsy for HCC in cirrhotic liver patient?(2021) Boyvat, F.; Ozen, O.; Soy, Ayvazoglu E. H.; Haberal, M.; 0000-0002-3462-7632; 0000-0002-0993-9917; AAJ-8097-2021; F-4230-2011; AAC-5566-2019Item A Case of Developing Rhino-Cerebral Mucormycosis After Liver Transplantation(2017) Turunc, T.; Kursun, E.; Demiroglu, Y. Z.; Aras, F.; Arlier, I.; Haberal, M.; 0000-0002-9866-2197; 0000-0002-3462-7632; 0000-0001-7956-7306; AAZ-9711-2021; AAJ-8097-2021; AAG-5020-2020Item Comparison of Isolated Transplant Glomerulopathy with Chronic Antibody Mediated Rejection in Regards to Endotbelial-to-Mesenchymal Transition and Graft Survival.(2019) Ozdemir, B.H.; Ozdemir, F. N.; Moray, G.; Haberal, M.Item Comparison of Pediatric Patients with Pure Antibody-Mediated Rejection (Amr) and Recipients with Both Amr and Vascular Rejection in the Development of Interstitial Fibrosis and Transplant Glomerulopathy(2017) Ozdemir, B. Handan; Ayva, S.; Baskin, E.; Ozdemir, F. Nurhan; Moray, G.; Haberal, M.; 0000-0002-7528-3557; 0000-0002-2280-8778; 0000-0003-4361-8508; 0000-0003-2498-7287; 0000-0002-3462-7632; X-8540-2019; AAK-1967-2021; B-5785-2018; AAE-1041-2021; AAJ-8097-2021Item Cutaneous Disorders in Liver Transplant Recipients(2014) Ozdemir, B.; Tepeoglu, M.; Taslica, Z.; Moray, G.; Haberal, M.; https://orcid.org/0000-0002-7528-3557; https://orcid.org/0000-0002-9894-8005; https://orcid.org/0000-0003-2498-7287; https://orcid.org/0000-0002-3462-7632; X-8540-2019; AAK-5222-2021; AAE-1041-2021; AAJ-8097-2021Item Cytomegalovirus (CMV) Infection Following Liver Transplantation: The Influence of CMV on Acute Rejection and Liver Fibrosis(2018) Ozgun, G.; Ozdemir, B. H.; Moray, G.; Haberal, M.; https://orcid.org/0000-0002-7528-3557; https://orcid.org/0000-0003-2498-7287; https://orcid.org/0000-0002-3462-7632; X-8540-2019; AAE-1041-2021; AAJ-8097-2021Item Cytomegalovirus (CMV) infection induces an angiogenic response through hepatic stellate cells (HSCs) and leads to early post-transplant liver fibrosis (LF) and poor graft survival(2019) Ozdemir, B. H.; Ozgun, G.; Soy, Ayvazoglu E. H.; Haberal, N.; Moray, G.; Haberal, M.Item Cytomegalovirus (CMV) Infection Induces an Angiogenic Response through Hepatic Stellate Cells (HSCs) and Leads to Early Post-Transplant Liver Fibrosis (LF) and Poor Graft Survival.(2019) Ozdemir, B.H.; Ozgun, G.; Soy, E.H. Ayvazoglu; Haberal, N.; Moray, G.; Haberal, M.; 0000-0002-0993-9917; AAC-5566-2019Item Diagnosis and Treatment of Xanthogranulomatous Cholecystitis(2014) Yabanoglu, H.; Aydogan, C.; Karakayali, F.; Moray, G.; Haberal, M.; https://orcid.org/0000-0002-1161-3369; https://orcid.org/0000-0003-1547-1297; https://orcid.org/0000-0002-1874-947X; https://orcid.org/0000-0003-2498-7287; https://orcid.org/0000-0002-3462-7632; 24817291; AAJ-7865-2021; AAJ-5296-2021; AAB-3888-2021; AAE-1041-2021; AAJ-8097-2021BACKGROUND: The aim of this study was to review our case load of the treatment and outcomes of patients with xanthogranulomatous cholecystitis (XGC). PATIENTS AND METHODS: Data about 21 patients were reviewed retrospectively to determine age, clinical symptoms and findings, preoperative screening, operative findings, surgical history, length of hospital stay, and postoperative complications. RESULTS: There were 14 men and 7 women (mean age, 65 +/- 11.3 yr). Preoperative ultrasonography of 17 patients showed a gallbladder stone in 14 patients, adenomyomatosis plus stones in 2 patients, and a polyp in 1 patient. There were 5 patients with acute cholecystitis and 16 patients with chronic cholecystitis. Gallbladder wall thickening was noted in 3 of the 12 patients who had abdominal computed tomography. Frozen section examinations were done in 5 patients. Radical cholecystectomy was done in 1 patient because of suspected carcinoma. CONCLUSIONS: It is difficult to diagnose XGC preoperatively or intraoperatively, and the definitive diagnosis depends exclusively on pathologic examination.